{
    "ticker": "NIVFW",
    "name": "Nivagen Pharmaceuticals, Inc.",
    "description": "Nivagen Pharmaceuticals, Inc. is a dynamic player in the pharmaceutical industry, specializing in the development and manufacturing of generic and specialty medications. Founded in 2013, Nivagen is committed to providing high-quality, affordable pharmaceuticals to improve patient access and health outcomes. The company focuses on a diverse range of therapeutic areas, including oncology, cardiology, and infectious diseases. By leveraging advanced technology and rigorous quality control processes, Nivagen ensures that its products meet the highest standards of safety and efficacy. Nivagen operates an FDA-approved manufacturing facility, which allows for the production of a wide variety of dosage forms, including tablets, capsules, and injectable solutions. The company's mission is to enhance the lives of patients by delivering innovative and reliable pharmaceutical solutions while maintaining a strong emphasis on sustainability and social responsibility. Nivagen is poised for growth as it expands its product portfolio and explores new market opportunities, including collaborations with healthcare providers and research institutions to drive innovation in drug development.",
    "industry": [
        "Pharmaceuticals"
    ],
    "headquarters": "Novi, Michigan, USA",
    "founded": "2013",
    "website": "https://www.nivagen.com",
    "ceo": "Karim A. Khamis",
    "social_media": {
        "twitter": "https://twitter.com/NivagenPharma",
        "linkedin": "https://www.linkedin.com/company/nivagen-pharmaceuticals/"
    },
    "investor_relations": "https://www.nivagen.com/investor-relations",
    "key_executives": [
        {
            "name": "Karim A. Khamis",
            "position": "CEO"
        },
        {
            "name": "Paul K. O'Donnell",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Generic Pharmaceuticals",
            "products": [
                "Oncology Drugs",
                "Cardiovascular Medications"
            ]
        },
        {
            "category": "Specialty Pharmaceuticals",
            "products": [
                "Injectable Solutions",
                "Controlled Substances"
            ]
        }
    ],
    "seo": {
        "meta_title": "Nivagen Pharmaceuticals, Inc. | Affordable Generic and Specialty Medications",
        "meta_description": "Discover Nivagen Pharmaceuticals, Inc., a leader in affordable generic and specialty medications. Learn about our commitment to quality and patient care.",
        "keywords": [
            "Nivagen",
            "Pharmaceuticals",
            "Generic Medications",
            "Specialty Drugs",
            "Affordable Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What does Nivagen Pharmaceuticals specialize in?",
            "answer": "Nivagen Pharmaceuticals specializes in the development and manufacturing of generic and specialty medications."
        },
        {
            "question": "Who is the CEO of Nivagen Pharmaceuticals?",
            "answer": "Karim A. Khamis is the CEO of Nivagen Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Nivagen Pharmaceuticals headquartered?",
            "answer": "Nivagen Pharmaceuticals is headquartered in Novi, Michigan, USA."
        },
        {
            "question": "What are Nivagen's main products?",
            "answer": "Nivagen's main products include oncology drugs and cardiovascular medications."
        },
        {
            "question": "When was Nivagen Pharmaceuticals founded?",
            "answer": "Nivagen Pharmaceuticals was founded in 2013."
        }
    ],
    "competitors": [
        "TEVA",
        "MCK",
        "AMGN"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "BMY",
        "MRK"
    ]
}